Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole and D-serine for Tourette Syndrome
NCT01018056Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Nov 2009
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of riluzole, d-serine in Tourette syndrome (TS), sponsored by Johns Hopkins University. Started Nov 2009; status: completed.
02
Drugs
riluzoled-serine
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT01018056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018056.